Suda Pharmaceuticals Ltd (SUD, formerly Suda Ltd) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. Administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), offers ease of use, lower dosage, reduced side effects and faster response time. SUDA operates solely in Australia. Former Names Eastland Medical Systems Ltd (EMS), 06/12/2012; Suda Ltd (SUD), 04/12/2017
Unit 12, Level 1/55 Howe St, Osborne Park WA 6017, Australia
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.